Note: This message is displayed if (1) your browser is not standards-compliant or (2) you have you disabled CSS. Read our Policies for more information.
An INSPECT report summarizes the controlled substances a patient has been prescribed, the practitioner who prescribed them and the dispensing pharmacy where the patient obtained them.
Professional Licensing Agency
Attn: INSPECT Program
402 W. Washington Street, Room W072
Indianapolis, Indiana 46204
Phone Number: 317-234-4458
Office Hours: 8:00 a.m. to 4:30 p.m. Monday through Friday
INSPECT was designed to serve as a tool to address the problem of prescription drug abuse and diversion in Indiana. By compiling controlled substance information into an online database (PMP Webcenter) INSPECT performs two critical functions:
INSPECT does not seek to limit the ability of doctors to perform their jobs effectively, nor does it intend to violate individual privacy or patient rights. Various security measures have been put in place to prevent abuse and ensure the confidentiality of patient medical records and other privileged information.
The Indiana General Assembly passed legislation in the mid-1990s that required the collection of controlled substance data through the Central Repository for Controlled Substances Data.
At its inception, Indiana’s Prescription Drug Monitoring program required licensed pharmacies in Indiana to report on dispensed schedule II controlled substances. In early 2004, grant funding and an act of the legislature helped create INSPECT in its present form, expanding reporting requirements to include schedule II through V controlled substances.
INSPECT continues to be partially funded through the Harold Rogers grant program, which provides similar funding in other states. Additional funding for INSPECT is provided at the state level, derived from a percentage of controlled substance licensing fees.
All data collection and maintenance activities for INSPECT are handled in-house. The data repository is accessible only to registered users and available only through a secure Web site maintained by program staff.
INSPECT is now sharing live data with Nevada! - Indiana now shares data with 18 states.
INSPECT is now sharing live data with Kentucky, making Indiana the FIRST state nationally to share data with ALL neighboring states! - INSPECT began sharing data with Kentucky this summer, completing the last step for Indiana to be completely surrounded and sharing data with all bordering states. Now when users of INSPECT make a request, they can choose to request data from any one or all of the 9 states INSPECT currently shares data with to be included on the report. This is a very exciting step forward in the fight against prescription drug abuse.
4th Annual Prescription Drug Abuse Symposium - The date for the 4th Annual Prescription Drug Abuse Symposium will be November 1st, 2013. Once registration materials are made available INSPECT will send the formal invite out to all registered INSPECT users and will post a link online here at www.in.gov/inspect for those interested in registering to attend.
INSPECT now sharing live data with Illinois - INSPECT is now sharing data with Illinois! INSPECT went live with data sharing to Illinois on Friday, March 8th, 2013. Now registered users may request that applicable records be included from Illinois when making a request for a patient Rx History Report. INSPECT is now only one state away from sharing data with all our neighboring states!
3rd Annual Prescription Drug Abuse Symposium - INSPECT will be presenting for the 3rd Annual Prescription Drug Abuse Symposium, which will be held downtown at the IUPUI Campus Center on December 19th, 2012.
INSPECT now sharing live data with Kansas, Arizona, Connecticut, and North Dakota - lNSPECT began sharing data with Kansas, Arizona, Connecticut, and North Dakota on 11/1/2012, in addition to Ohio, Michigan and Virginia. Now users of INSPECT will be able to request records from any of these states when making a request. Registered users of those state prescription monitoring programs will also be able to request records from Indiana. INSPECT anticipates sharing data with Kentucky and Illinois very soon, which will make Indiana the first state to share data with all surrounding border states!
New Helpdesk now in place - INSPECT has implemented a new online Helpdesk to handle all inquiries and requests to the program. This will allow staff to respond to all requests and emails in a timely manner and to better serve the program's users and stakeholders. Please complete a Helpdesk ticket for any assistance needed with the program so that staff can resolve issues thoroughly and quickly.
INSPECT now sharing live data with Michigan - lNSPECT began sharing data with Michigan on 5/11/2012. Now users of INSPECT will be able to request records from Michigan, along with Ohio and Virginia. Similarly, registered users of Michigan's MAPS prescription monitoring program will also be able to request records from Indiana.
INSPECT's New User-Led Unsolicited Reporting (ULUR) feature is ready for use! - lNSPECT is happy to announce the release of our newest reporting feature, the user-led unsolicited reporting (ULUR) function. This function is available for use by all "practitioner" accounts and will allow users to forward a copy of an Rx History Report to mutual treatment providers listed on that report. For more information, please refer to the guide below. Email INSPECT at firstname.lastname@example.org or submit a HelpDesk ticket with any questions or issues.
INSPECT now sharing live data with Ohio - lNSPECT is excited to announce the release of the new PMPi feature in the WebCenter. This function will allow practitioner users to check a box which will request prescription data from Ohio as well as Indiana to be included on the Rx History Reports. Sharing prescription data will enable practitioners around the state borders to have full access to patient records whether the prescription was written or filled in Indiana or Ohio. This will enable INSPECT users to identify potential doctor-shoppers or drug seekers that are crossing the border to obtain prescriptions and vice versa. Please review the documents below for more information on this exciting new feature.